17593950|t|Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells.
17593950|a|Neuronal apoptosis is involved in neurodegenerative diseases such as Alzheimer's disease and Parkinson.s disease. An efficient means of preventing it remains to be found. Some n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA, 22 : 6n-3) and eicosapentaenoic acid (EPA, 20 : 5n-3) have been reported to be protective against the neuronal apoptosis and neuronal degeneration seen after spinal cord injury (SCI) [1]. However, it is unclear which kinds of PUFAs have the most potent ability to inhibit neuronal apoptosis and whether the simultaneous treatment of PUFAs inhibits the apoptosis. In the present study, we compared the abilities of various n-3- and n-6- PUFAs to inhibit the apoptosis induced after the administration of different apoptotic inducers, etoposide, okadaic acid, and AraC, in mouse neuroblastoma cells (Neuro2a). Preincubation with DHA (22 : 6n-3), eicosapentaenoic acid (EPA, 20 : 5n-3), alpha-linolenic acid (alpha-LNA, 18 : 3n-3), linoleic acid (LA, 18 : 2n-6), arachidonic acid (AA, 20 : 4n-3), and gamma-linolenic acid (gamma-LNA, 18 : 3n-6) significantly inhibited caspase-3 activity and LDH leakage but simultaneous treatment with the PUFAs had no effect on the apoptosis of Neuro2a cells. There were no significant differences of the anti-apoptotic eff ect among the PUFAs. These results suggest that PUFAs may not be effective for inhibiting neuronal cell death after acute and chronic neurodegenerative disorders. However, dietary supplementation with PUFAs may be beneficial as a potential means to delay the onset of the diseases and/or their rate of progression.
17593950	21	48	polyunsaturated fatty acids	Chemical	MESH:D005231
17593950	73	82	etoposide	Chemical	MESH:D005047
17593950	84	96	okadaic acid	Chemical	MESH:D019319
17593950	101	105	AraC	Chemical	MESH:D003561
17593950	109	116	Neuro2a	CellLine	CVCL:0470
17593950	124	142	Neuronal apoptosis	Disease	MESH:D065703
17593950	158	184	neurodegenerative diseases	Disease	MESH:D019636
17593950	193	212	Alzheimer's disease	Disease	MESH:D000544
17593950	217	236	Parkinson.s disease	Disease	MESH:D010300
17593950	300	331	n-3 polyunsaturated fatty acids	Chemical	MESH:D015525
17593950	333	338	PUFAs	Chemical	MESH:D005231
17593950	348	368	docosahexaenoic acid	Chemical	MESH:D004281
17593950	370	373	DHA	Chemical	MESH:D004281
17593950	375	384	22 : 6n-3	Chemical	-
17593950	390	411	eicosapentaenoic acid	Chemical	MESH:D015118
17593950	413	416	EPA	Chemical	MESH:D015118
17593950	418	427	20 : 5n-3	Chemical	-
17593950	477	495	neuronal apoptosis	Disease	MESH:D065703
17593950	500	521	neuronal degeneration	Disease	MESH:D009410
17593950	533	551	spinal cord injury	Disease	MESH:D013119
17593950	553	556	SCI	Disease	MESH:D013119
17593950	601	606	PUFAs	Chemical	MESH:D005231
17593950	647	665	neuronal apoptosis	Disease	MESH:D065703
17593950	708	713	PUFAs	Chemical	MESH:D005231
17593950	797	816	n-3- and n-6- PUFAs	Chemical	-
17593950	908	917	etoposide	Chemical	MESH:D005047
17593950	919	931	okadaic acid	Chemical	MESH:D019319
17593950	937	941	AraC	Chemical	MESH:D003561
17593950	946	965	mouse neuroblastoma	Species	
17593950	973	980	Neuro2a	CellLine	CVCL:0470
17593950	1002	1005	DHA	Chemical	MESH:D004281
17593950	1007	1016	22 : 6n-3	Chemical	-
17593950	1019	1040	eicosapentaenoic acid	Chemical	MESH:D015118
17593950	1042	1045	EPA	Chemical	MESH:D015118
17593950	1047	1056	20 : 5n-3	Chemical	-
17593950	1059	1079	alpha-linolenic acid	Chemical	MESH:D017962
17593950	1081	1090	alpha-LNA	Chemical	MESH:D017962
17593950	1092	1101	18 : 3n-3	Chemical	MESH:D017962
17593950	1104	1117	linoleic acid	Chemical	MESH:D019787
17593950	1123	1132	18 : 2n-6	Chemical	-
17593950	1135	1151	arachidonic acid	Chemical	MESH:D016718
17593950	1157	1166	20 : 4n-3	Chemical	-
17593950	1173	1193	gamma-linolenic acid	Chemical	MESH:D017965
17593950	1195	1204	gamma-LNA	Chemical	MESH:D017965
17593950	1206	1215	18 : 3n-6	Chemical	MESH:D017965
17593950	1241	1250	caspase-3	Gene	12367
17593950	1312	1317	PUFAs	Chemical	MESH:D005231
17593950	1352	1359	Neuro2a	CellLine	CVCL:0470
17593950	1445	1450	PUFAs	Chemical	MESH:D005231
17593950	1479	1484	PUFAs	Chemical	MESH:D005231
17593950	1521	1529	neuronal	Disease	MESH:D009410
17593950	1565	1592	neurodegenerative disorders	Disease	MESH:D019636
17593950	1632	1637	PUFAs	Chemical	MESH:D005231
17593950	Negative_Correlation	MESH:D005047	MESH:D005231
17593950	Negative_Correlation	MESH:D004281	MESH:D013119
17593950	Negative_Correlation	MESH:D017965	12367
17593950	Negative_Correlation	MESH:D019787	12367
17593950	Negative_Correlation	MESH:D003561	MESH:D005231
17593950	Negative_Correlation	MESH:D004281	MESH:D065703
17593950	Negative_Correlation	MESH:D015525	MESH:D013119
17593950	Negative_Correlation	MESH:D004281	12367
17593950	Negative_Correlation	MESH:D015118	MESH:D009410
17593950	Negative_Correlation	MESH:D017962	12367
17593950	Negative_Correlation	MESH:D015525	MESH:D065703
17593950	Negative_Correlation	MESH:D005231	MESH:D065703
17593950	Negative_Correlation	MESH:D016718	12367
17593950	Negative_Correlation	MESH:D015118	MESH:D065703
17593950	Negative_Correlation	MESH:D005231	MESH:D019319
17593950	Negative_Correlation	MESH:D005231	MESH:D013119
17593950	Negative_Correlation	MESH:D015118	12367
17593950	Negative_Correlation	MESH:D015118	MESH:D013119
17593950	Negative_Correlation	MESH:D004281	MESH:D009410

